Clinical Trials List
2025-12-08 - 2030-12-31
Phase III
Not yet recruiting1
Recruiting1
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Inn-Wen Chong 無
- Chih-Jen Yang 無
- 李玫萱 無
- 李岱晃 無
- 莊政皓 無
- 郭家佑 無
- Ying-Ming Tsai Tsai 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 吳尚俊 無
- JIN-YUAN SHIH 無
- 廖斌志 無
- Chia-Chi Lin 無
- 林宗哲 無
- 黃信端 無
- YEN-TING LIN 無
- 黃得瑞 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
16 participants
-
Global
480 participants
